DY
RGLS
Dowling & Yahnke’s Regulus Therapeutics RGLS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-12,000
| Closed | -$4K | – | 385 |
|
|
2022
Q1 | $4K | Hold |
12,000
| – | – | ﹤0.01% | 375 |
|
|
2021
Q4 | $4K | Hold |
12,000
| – | – | ﹤0.01% | 377 |
|
|
2021
Q3 | $8K | Hold |
12,000
| – | – | ﹤0.01% | 372 |
|
|
2021
Q2 | $10K | Hold |
12,000
| – | – | ﹤0.01% | 367 |
|
|
2021
Q1 | $19K | Hold |
12,000
| – | – | ﹤0.01% | 337 |
|
|
2020
Q4 | $16K | Hold |
12,000
| – | – | ﹤0.01% | 327 |
|
|
2020
Q3 | $6K | Hold |
12,000
| – | – | ﹤0.01% | 307 |
|
|
2020
Q2 | $8K | Buy |
+12,000
| New | +$8K | ﹤0.01% | 294 |
|
|
2018
Q4 | – | Sell |
-12,000
| Closed | -$2K | – | 275 |
|
|
2018
Q3 | $2K | Hold |
12,000
| – | – | ﹤0.01% | 282 |
|
|
2018
Q2 | $8K | Hold |
12,000
| – | – | ﹤0.01% | 275 |
|
|
2018
Q1 | $9K | Buy |
12,000
+500
| +4% | +$375 | ﹤0.01% | 280 |
|
|
2017
Q4 | $12K | Hold |
11,500
| – | – | ﹤0.01% | 291 |
|
|
2017
Q3 | $14K | Hold |
11,500
| – | – | ﹤0.01% | 277 |
|
|
2017
Q2 | $11K | Hold |
11,500
| – | – | ﹤0.01% | 276 |
|
|
2017
Q1 | $19K | Buy |
+11,500
| New | +$19K | ﹤0.01% | 276 |
|